Arthur Waldbaum

1.4k total citations
23 papers, 1.0k citations indexed

About

Arthur Waldbaum is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Genetics. According to data from OpenAlex, Arthur Waldbaum has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Reproductive Medicine and 7 papers in Genetics. Recurrent topics in Arthur Waldbaum's work include Menopause: Health Impacts and Treatments (10 papers), Estrogen and related hormone effects (7 papers) and Reproductive tract infections research (7 papers). Arthur Waldbaum is often cited by papers focused on Menopause: Health Impacts and Treatments (10 papers), Estrogen and related hormone effects (7 papers) and Reproductive tract infections research (7 papers). Arthur Waldbaum collaborates with scholars based in United States, United Kingdom and Australia. Arthur Waldbaum's co-authors include Céline Bouchard, Susan R. Davis, Christine Derzko, Cynthia Rodenberg, Akshay Buch, James A. Simon, Wulf H. Utian, Robin Kroll, Johna Lucas and Molly Katz and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and American Journal of Obstetrics and Gynecology.

In The Last Decade

Arthur Waldbaum

23 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arthur Waldbaum United States	14	716	442	274	208	157	23	1.0k
Stefania Alvisi Italy	16	220 0.3×	143 0.3×	69 0.3×	240 1.2×	57 0.4×	29	679
Brian Bernick United States	19	820 1.1×	146 0.3×	522 1.9×	197 0.9×	337 2.1×	60	1.0k
Ellis Martini Italy	12	332 0.5×	349 0.8×	61 0.2×	119 0.6×	81 0.5×	27	624
Sebastián Carranza‐Lira Mexico	17	212 0.3×	40 0.1×	172 0.6×	309 1.5×	75 0.5×	93	872
Craig Niederberger United States	17	456 0.6×	587 1.3×	107 0.4×	634 3.0×	17 0.1×	81	1.5k
Silvia Martella Italy	9	230 0.3×	235 0.5×	49 0.2×	77 0.4×	61 0.4×	17	451
Nancy Phillips United States	11	159 0.2×	156 0.4×	25 0.1×	67 0.3×	25 0.2×	21	372
M. Savvas United Kingdom	19	376 0.5×	40 0.1×	256 0.9×	298 1.4×	85 0.5×	37	917
Ana Carolina Japur de Sá Rosa e Silva Brazil	20	162 0.2×	175 0.4×	83 0.3×	767 3.7×	31 0.2×	83	1.1k
Paolo Busacchi Italy	16	164 0.2×	193 0.4×	30 0.1×	285 1.4×	19 0.1×	37	653

Countries citing papers authored by Arthur Waldbaum

Since Specialization

Citations

This map shows the geographic impact of Arthur Waldbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Waldbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Waldbaum more than expected).

Fields of papers citing papers by Arthur Waldbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Waldbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Waldbaum. The network helps show where Arthur Waldbaum may publish in the future.

Co-authorship network of co-authors of Arthur Waldbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Waldbaum. A scholar is included among the top collaborators of Arthur Waldbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Waldbaum. Arthur Waldbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwebke, Jane R., Arthur Waldbaum, Kathy Agnew, et al.. (2021). A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 10. 100121–100121. 20 indexed citations

Fraser, Graeme L., Samuel Lederman, Arthur Waldbaum, et al.. (2020). A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause. Menopause The Journal of The North American Menopause Society. 27(4). 382–392. 75 indexed citations

Waldbaum, Arthur, Jane R. Schwebke, Jeremy Ra Paull, et al.. (2020). A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. PLoS ONE. 15(5). e0232394–e0232394. 18 indexed citations

Santoro, Nanette, Arthur Waldbaum, Samuel Lederman, et al.. (2020). Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Menopause The Journal of The North American Menopause Society. 27(12). 1350–1356. 44 indexed citations

Chavoustie, Steven, Arthur Waldbaum, Gilbert Donders, et al.. (2019). Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 245. 13–18. 24 indexed citations

Fraser, Graeme L., Samuel Lederman, Arthur Waldbaum, et al.. (2019). OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study. Journal of the Endocrine Society. 3(Supplement_1). 3 indexed citations

Archer, David F., Steven R. Goldstein, James A. Simon, et al.. (2019). Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. Menopause The Journal of The North American Menopause Society. 26(6). 611–621. 44 indexed citations

Schwebke, Jane R., Arthur Waldbaum, Clare F. Price, et al.. (2019). Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis. American Journal of Obstetrics and Gynecology. 221(6). 672–673. 5 indexed citations

Fraser, Graeme L., Samuel Lederman, Arthur Waldbaum, et al.. (2019). The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study. Maturitas. 124. 135–135. 2 indexed citations

10.

Hillier, Sharon L., et al.. (2017). Secnidazole Treatment of Bacterial Vaginosis. Obstetrics and Gynecology. 130(2). 379–386. 27 indexed citations

11.

Hillier, Sharon L., et al.. (2015). 6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis. American Journal of Obstetrics and Gynecology. 213(6). 885–885. 5 indexed citations

12.

Labrie, Fernand, David F. Archer, Céline Bouchard, et al.. (2015). Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 81(1). 46–56. 44 indexed citations

13.

Chavoustie, Steven, Mark Jacobs, Arthur Waldbaum, et al.. (2014). Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Journal of Lower Genital Tract Disease. 19(2). 129–134. 18 indexed citations

14.

Bouchard, Céline, Fernand Labrie, David F. Archer, et al.. (2014). Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric. 18(4). 590–607. 35 indexed citations

15.

Muse, Ken, et al.. (2012). Tranexamic Acid Increases Hemoglobin and Ferritin Levels in Women with Heavy Menstrual Bleeding. Journal of Women s Health. 21(7). 756–761. 11 indexed citations

16.

Muse, Ken, Janet Gersten, Arthur Waldbaum, et al.. (2010). Long-term quality of life and safety of a new tranexamic acid menorrhagia treatment. Fertility and Sterility. 94(4). S13–S13. 2 indexed citations

17.

Simon, James A., et al.. (2007). Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women. Obstetrics and Gynecology. 109(3). 588–596. 55 indexed citations

18.

Shifren, Jan L., Susan R. Davis, Michèle Moreau, et al.. (2006). Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women. Menopause The Journal of The North American Menopause Society. 13(5). 770–779. 226 indexed citations

19.

Simon, James A., Glenn D. Braunstein, Lila E. Nachtigall, et al.. (2005). Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5226–5233. 343 indexed citations

20.

Waldbaum, Arthur, et al.. (2002). Acceptability of NuvaRing®, a new method of combined contraception. Fertility and Sterility. 78. S25–S25. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact